T-cell lymphoma is a rare cancer that affects the lymphatic system. Learn about the types, signs, symptoms, treatments, and ...

Sanofi is buying an immunology drug from Dren Bio, Inc. for up to $1.9 billion, in a deal it said will help it become a ...

and non-Hodgkin lymphoma (NHL). Rashes in HL aren’t very common but can occur as a symptom of the disease or as a side effect of some treatments. Rashes are more likely to occur in NHL ...

A six-year-old playful girl’s limp was dismissed by doctors as “growing pains” until an MRI scan revealed non-Hodgkin's ...

Sanofi SNY announced that it signed an agreement with California-based privately held biopharmaceutical company Dren Bio to ...

Evidence that smoking causes non-Hodgkin’s lymphoma is mixed ... immune system and makes your body less capable of fighting disease. Smoking also increases the risk of some autoimmune diseases ...

The FDA has granted fast-track designation to nipocalimab for the treatment of Sjögren’s disease, according to a press ...

The survival rate of non-Hodgkin’s lymphoma is generally lower ... without the cancer to isolate deaths directly caused by the disease. For example, a relative 5-year overall survival rate ...

The most common symptom of non-Hodgkin lymphoma is a painless swelling ... she is on a similar treatment plan to an adult with the disease. “She started treatment the week she was supposed ...

Bexobrutideg, a bioavailable agent, was granted orphan drug designation by the FDA for Waldenström macroglobulinemia, a type ...

MRI may also be useful in the follow-up of breast lymphoma patients to monitor response to chemotherapy and radiotherapy and to diagnose disease recurrence. Primary non-Hodgkin's lymphoma of the ...

An early pilot trial suggests that combining atezolizumab (tecectriq) with rituximab (Rituxan), gemcitabine (gemzar) and ...